Today we're speaking with Dr. Ivan Kairatov, a biopharma expert whose work is at the very intersection of technology and immunology. His research has illuminated a fundamental biochemical pathway that governs how our immune cells maintain the health of our organs. We’ll be exploring his recent
A groundbreaking collaborative study has revealed a critical vulnerability within the human immune system, uncovering a sophisticated mechanism of viral sabotage that fundamentally alters our understanding of how pathogens outsmart our natural defenses. Research has identified a single tissue
For millions of people who rely on proton pump inhibitors (PPIs) to manage chronic acid reflux and other gastrointestinal conditions, a persistent concern has long cast a shadow over their treatment: the potential risk of developing stomach cancer. This decades-old question has fueled anxiety among
The same biological process that heroically defends the body against injury and infection can become a relentless saboteur when it fails to disengage, driving many of modern medicine's most formidable chronic diseases. For decades, the focus of anti-inflammatory treatment has been on suppressing
The arduous journey of a new drug from a laboratory concept to a patient's hands is a monumental undertaking, an odyssey fraught with staggering costs, extensive research, and an alarmingly high probability of failure. For every ten promising drug candidates that enter the rigorous phase of human
The escalating crisis of metabolic disease is silently fueling a surge in liver cancer cases worldwide, forcing researchers to seek innovative strategies that can halt this deadly progression before it begins. A class of drugs originally developed for diabetes, known as nutrient-stimulated
